Tubulis announced today that its second drug candidate, TUB-030, has entered clinical evaluation with successful dosing of the first patient in the 5-STAR 1-01 Phase I/IIa trial (NCT06657222). The ...

The firm will share new overall survival data from the INAVO120 trial with regulators to support the breast cancer drug's approval.

William Bremer; Analyst; Vanquish Capital Partners Ltd.

A retired Black Hawk helicopter pilot from Wisconsin offered insight into the deadly air crash that happened at Reagan Washington National Airport.

Operator Good day, ladies and gentlemen, and welcome to Northrop Grumman's fourth quarter 2024 conference call. Today's call ...

Nathan Baxter; Chief Operating Officer, Executive Vice President; Scotts Miracle-Gro Co Jon Andersen; Analyst; William Blair & Co., LLC Eric Bossard; Analyst; Cleveland Research Company ...

Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.